Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Milestone Pharmaceuticals Inc. (MIST)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Jun-30-23 | Mar-31-23 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 |
| | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q |
| Revenues | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | | 100.0% | 100.0% |
| Cost of goods sold | 0.0% | 0.0% | 178.0% | 0.0% | 0.0% | | 0.0% | 12.3% |
| Gross profit | 100.0% | 100.0% | -78.0% | 100.0% | 100.0% | | 100.0% | 87.7% |
| Research and development | -255.9% | -756.4% | 655.1% | -477.7% | -535.9% | | -616.4% | 62.8% |
| General and administrative | -131.9% | -286.8% | 268.9% | -175.6% | -222.7% | | -187.5% | 20.1% |
| Depreciation | -0.7% | -1.3% | 1.8% | -1.1% | -1.4% | | -1.5% | 0.2% |
| EBIT | 487.9% | 1143.2% | -1002.0% | 753.3% | 858.6% | | 903.9% | 4.7% |
| Pre-tax income | 476.2% | 1102.5% | -970.4% | 746.2% | 856.2% | | 900.9% | 5.1% |
| Income taxes | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | | 0.0% | 0.0% |
| Net income | 476.2% | 1102.5% | -970.4% | 746.2% | 856.2% | | 900.9% | 5.1% |
|